CEREBROSPINAL FLUID AMYLOID BETA AND GLIAL FIBRILLARY ACIDIC PROTEIN CONCENTRATIONS IN HUNTINGTON'S DISEASE

被引：0
|
作者：
Korpela, Sara [1 ]
Sundblom, Jimmy [2 ]
Zetterberg, Henrik [3 ]
Constantinescu, Radu [4 ,5 ]
Svenningsson, Per [6 ]
Arce, Martin Paucar [6 ]
Niemela, Valter [7 ]
机构：
[1] Vasteras Hosp, Dept Med, Neurol, Vasteras, Sweden
[2] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal Gothenburg, Sweden
[4] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden
[5] Univ Gothenburg, Sahlgrenska Acad, Clin Neurosci, Gothenburg, Sweden
[6] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[7] Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2021年 / 92卷
关键词：
D O I：
10.1136/jnnp-2021-EHDN.33
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
D02
引用
收藏
页码：A14 / A14
页数：1
相关论文
共 50 条
  • [1] Cerebrospinal fluid glial fibrillary acidic protein, in contrast to amyloid beta protein, is associated with disease symptoms in Huntington's disease
    Korpela, Sara
    Sundblom, Jimmy
    Zetterberg, Henrik
    Constantinescu, Radu
    Svenningsson, Per
    Paucar, Martin
    Niemela, Valter
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 459
  • [2] Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia
    Wallin, A
    Blennow, K
    Rosengren, LE
    DEMENTIA, 1996, 7 (05): : 267 - 272
  • [3] DETERMINATION OF S-100 AND GLIAL FIBRILLARY ACIDIC PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID AFTER BRAIN INFARCTION
    AURELL, A
    ROSENGREN, LE
    KARLSSON, B
    OLSSON, JE
    ZBORNIKOVA, V
    HAGLID, KG
    STROKE, 1991, 22 (10) : 1254 - 1258
  • [4] Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
    You, Huajing
    Wu, Tengteng
    Du, Gang
    Huang, Yue
    Zeng, Yixuan
    Lin, Lishan
    Chen, Dingbang
    Wu, Chao
    Li, Xunhua
    Burgunder, Jean-marc
    Pei, Zhong
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [5] Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
    Wu, Tengteng
    Zeng, Yixuan
    Lin, Lishan
    Chen, Dingbang
    Wu, Chao
    Yang, Huihua
    Xunhua, L.
    Pei, Zhong
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 11 - 11
  • [6] The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia
    Fukuyama, R
    Izumoto, T
    Fushiki, S
    EUROPEAN NEUROLOGY, 2001, 46 (01) : 35 - 38
  • [7] DEVICS SYNDROME - ANTIBODY TO GLIAL FIBRILLARY ACIDIC PROTEIN IN CEREBROSPINAL-FLUID
    CHOU, CHJ
    CHOU, FCH
    TOURTELLOTTE, WW
    KIBLER, RF
    NEUROLOGY, 1984, 34 (01) : 86 - 88
  • [8] Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
    Freigang, Maren
    Steinacker, Petra
    Wurster, Claudia D.
    Schreiber-Katz, Olivia
    Osmanovic, Alma
    Petri, Susanne
    Koch, Jan C.
    Rostasy, Kevin
    Huss, Andre
    Tumani, Hayrettin
    Winter, Benedikt
    Falkenburger, Bjorn
    Ludolph, Albert C.
    Otto, Markus
    Hermann, Andreas
    Guenther, Rene
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (09): : 1437 - 1448
  • [9] Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis
    Nylén, K
    Karlsson, JE
    Blomstrand, C
    Tarkowski, A
    Trysberg, E
    Rosengren, LE
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (06) : 844 - 851
  • [10] Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy
    Feneberg, Emily
    Steinacker, Petra
    Lehnert, Stefan
    Boehm, Bernhard
    Mayer, Geert
    Otto, Markus
    SLEEP MEDICINE, 2013, 14 (07) : 692 - 694
12345